v3 Template
O

Oncolytics Biotech Inc.

Biotechnology / Healthcare Vancouver, BC, Canada ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$35.0M
Funding Rounds
3
Last Funding
2023-09-26

About Oncolytics Biotech Inc.

Oncolytics Biotech is dedicated to improving the lives of cancer patients by developing pelareorep, a unique immunotherapy that activates the immune system to fight tumors. Their mission is to provide more quality time to patients by unlocking the antitumor potential of the immune system through innovative treatments.

Products & Services

Pelareorep:A unique immunotherapy delivered intravenously, designed to awaken the immune system and fight tumors by turning immunologically 'cold' tumors 'hot'. It can be used as a single agent or combined with other therapies like chemotherapy and checkpoint inhibitors to enhance tumor-fighting capabilities, showing potential in HR+/HER2- breast cancer and pancreatic cancer.

Specialties

Immunotherapy Oncology Cancer Treatment Pelareorep Development Immune System Activation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 5000000
MR: -
FA: $5 million
FAN: 5000000
D: 2023-09-26
FD: 2023-09-26
1 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 15000750
MR: -
FA: US$15,000,750
FAN: 15000750
D: 2023-08-08
FD: 2023-08-08
2 investors
3 RT: Equity Offering
T: -
FT: Equity Offering
A: 15000750
MR: -
FA: US$15,000,750
FAN: 15000750
D: 2023-07-31
FD: 2023-07-31
1 investors
Grant Latest
2023-09-26
$5.0M
1 investor (Pro only)
Public Offering 2023-08-08
$15.0M
Equity Offering 2023-07-31
$15.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jared Kelly

Chief Executive Officer & Director

K

Kirk Look

Chief Financial Officer

T

Thomas C. Heineman

Chief Medical Officer

A

Allison Hagerman

Vice President, Product Development

A

Andrew Aromando

Chief Business Officer

A

Amy Levin

Vice President, Clinical Operations

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Oncolytics Biotech Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~360 employees (est.)
Locations
Vancouver, BC, Canada
SAN DIEGO and CALGARY, AB
SAN DIEGO and CALGARY +2 more

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro